Aminoacyl-tRNA synthetase inhibitors as potent antibacterials

Current Medicinal Chemistry

Volumn 19, Issue 21, 2012, Pages 3550-3563

  Lv, P C ^a   Zhu, H L ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Aminoacyl tRNA synthetases (AaRS); Antibacterial agents; Isoleucyl tRNA synthetase; Methionyl tRNA synthetase; Phenylalanyl tRNA synthetase inhibitors

Indexed keywords

2,3 DIHYDROREVEROMYCIN A; AMINOACYL TRANSFER RNA; AMINOACYL TRANSFER RNA SYNTHETASE INHIBITOR; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; ISOLEUCYL TRANSFER RNA SYNTHETASE INHIBITOR; METHIONYL TRANSFER RNA SYNTHETASE INHIBITOR; PHENYLALANYL TRANSFER RNA SYNTHETASE INHIBITOR; PSEUDOMONIC ACID; REVEROMYCIN A; THIOMARINOL A; THIOMARINOL H; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; CATALYSIS; CELL SURVIVAL; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; IMPETIGO; PROTEIN SYNTHESIS; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84863746046     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712801323199     Document Type: Review

References (52)

1. Tao, J.; Wendler, P.; Connelly, G.; Lim, A.; Zhang, J.; King, M.; Li, T.; Silverman, J.A.; Schimmel, P.R.; Tally, F.P. Drug target validation: Lethal infection blocked by inducible peptide. Proc. Natl. Acad. Sci. USA, 2000, 97, 783-786.
2. Ibba, M.; Soll, D. Aminoacyl-tRNAs synthesis. Annu. Rev. Biochem., 2000, 69, 617-650.
3. Cashel, M.; Gentry, D. R.; Hernandez, V. J.; Vinella, D. Escherichia coli and Salmonella: cellular and molecular microbiology, vol. 1, 2nd ed. ASM Press, Washington, D.C., 1996, 1458-1496.
4. Cassels, R.; Oliva, B.; Knowles, D. Occurrence of the regulatory nucleotides ppGpp and pppGpp following induction of the stringent response in staphylococci. J. Bacteriol., 1995, 177, 5161-5165.
5. Ogilvie, A.; Wiebauer, K; Kersten, W. Stringent control of ribonucleic acid synthesis in Bacillus subtilis treated with granaticin. Biochem. J., 1975, 152, 517-522.
6. Wilson, J. M.; Oliva, B.; Cassels, R.; O'Hanlon, P. J.; Chopra, I. SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob. Agents Chemother, 1995, 39, 1925-1933.
7. Goldman, E.; Jakubowski, H. Uncharged tRNA, protein synthesis, and the bacterial stringent response. Mol. Microbiol. 1990, 4, 2035-2040.
8. Eriani, G.; Delarue, M.; Poch, O.; Gangloff, J.; Moras, D. Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature, 1990, 347, 203-206.
9. Hurdle, J.G.; O'Neill, A.J.; Chopra, I. Prospects for Aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents. Antimicrob. Agents Chemother., 2005, 49, 4821-4833.
10. Raczniak, G.; Ibba, M.; Soll, D. Genomics-based identification of targets in pathogenic bacteria for potential therapeutic and diagnostic use. Toxicology, 2001, 160, 181-189.
11. Gallant, P.; Finn, J.; Keith, D.; Wendler, P. Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents. Expert Opin. Ther. Targets, 2000, 4, 1-9.
12. Macarron, R.; Mensah, L.; Cid, C.; Carranza, C.; Benson, N.; Pope, A. J.; Diez, E. A homogeneous method to mea-jacyl-tRNA synthetase aminoacylation activity using scintillation prox-y technology. Anal. Biochem., 2000, 284, 183-190.
13. Pohlmann, J.; Brotz-Oesterhelt, H. New aminoacyl-tRNA synthetase inhibitors as antibacterial agents. Curr. Drug Targets Infect. Disord., 2004, 4, 261-272.
14. Kim, S. Y.; Lee, Y. S.; Kang, T.; Kim, S.; Lee, J. Pharmacophore-based virtual screening: The discovery of novel methionyl-tRNA synthetase inhibitors. Bioorg. & Med. Chem. Lett., 2006, 16, 4898-4907
15. Jo, Y. J.; Lee, S. W.; Jo, M. K.; Lee, J.; Kang, M.-K.; Yoon, J. H.; Kim, S. J. Biochem. Mol. Biol., 1999, 32, 547.
16. Macarron, R.; Mensah, L.; Cid, C.; Carranza, C.; Benson, N.; Pope, A. J.; Diez, E. A homogeneous method to measure aminoacyl-tRNA synthetase aminoacylation activity using scintillation proximity assay technology. Anal. Biochem., 2000, 284, 183-190.
17. Crepin, T.; Schmitt, E.; Mechulam, Y.; Sampson, P. B.; Vaughan, M. D.; Honek, J. F.; Blanquet, S. Use of analogues of methionine and methionyl adenylate to sample conformational changes during catalysis in Escherichia coli methionyl-tRNA synthetase. J. Mol. Biol., 2003, 332, 59-72.
18. Tandon, M.; Coffen, D. L.; Gallant, P.; Keith, D.; Ashwell, M. A. Potent and Selective Inhibitors of Bacterial Methionyl tRNA Synthetase Derived from an Oxazolone-Dipeptide Scaffold. Bioorg. Med. Chem. Lett., 2004, 14, 1909-1911.
19. Lee, J.; Kang, M.; Kyoung, C.; Moon, W.; Jo, Y.; Kwak, J.; Kim, S. Methionine analogues as inhibitors of methionyl-tRNA synthetase. Bioorg. Med. Chem. Lett., 1998, 8, 3511-3514.
20. Lee, J.; Kang, S.; Kang, M.; Chun, M.; Jo, Y.; Kwak, J.; Kim, S. Methionyl adenylate analogues as inhibitors of methionyl-tRNA synthetase. Bioorg. Med. Chem. Lett., 1999, 9, 1365-1370.
21. Jarvest, R.; Berge, J.; Berry, V.; Boyd, H.; Brown, M.; Elder, J.; Forrest, A.; Fosberry, A.; Gentry, D.; Hibbs, M.; Jaworski, D.; O' Hanlon, P.; Pope, A.; Rittenhouse, S.; Sheppard, R.; Slater-Radosti, C.; Worby, A. Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens. J. Med. Chem., 2002, 45, 1959-1962.
22. Finn, J.; Mattia, K.; Morytko, M.; Ram, S.; Yang, Y.; Wu, X.; Mak, E.; Gallant, P.; Keith, D. Discovery of a Potent and Selective Series of Pyrazole Bacterial Methionyl-tRNA Synthetase Inhibitors. Bioorg. Med. Chem. Lett., 2003, 13, 2231-2234.
23. Pope, A. J.; Moore, K. J.; McVey, M.; Mensah, L.; Benson, N.; Osborne, N.; Broom, N.; Brown, M. J. B.; O'Hanlon, P. Characterization of Isoleucyl-tRNA Synthetase from Staphylococcus aureus. J. Biol. Chem., 1998, 48, 31691-31701.
24. Finn J, Stidham M, Hilgers M, Identification of novel inhibitors of methionyl-tRNA synthetase (MetRS) by virtual screening. Bioorg. Med. Chem. Lett., 2008, 18, 3932-3937.
25. Güner, O.; Clement, O.; Kurogi, Y. Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. Curr. Med. Chem. 2004, 11, 2991-3005.
26. Takahashi, H.; Osada, H.; Koshino, H.; Kudo, T.; Amano, S.; Shimizu, S.; Yoshihama, M.; Isono, K. Reveromycins, new inhibitors of eukaryotic cell growth. I. Producing organism, fermentation, isolation and physico-chemical properties. J. Antibiot., 1992, 45, 1409-1413.
27. Miyamoto, Y.; Machida, K.; Mizunuma, M.; Emoto, Y.; Sato, N.; Miyahara, K.; Usui, T.; Osada, H.; Takahashi, H.; Hirata, D.; Miyakawa, T. Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as a target of the G1-specific inhibitor Reveromycin A. J. Biol. Chem., 2002, 277, 28810-28814.
28. Koshino, H.; Takahashi, H.; Osada, H.; Isono, K. Reveromycins, new inhibitors of eukaryotic cell growth. III. Structures of reveromycins A, B, C and D. J. Antibiot., 1992, 45, 1420-1427.
29. Ubukata, M.; Koshino, H.; Osada, H.; Isono, K. Absolute configuration of reveromycin A, an inhibitor of the signal transduction of epidermal growth factor. J. Chem. Soc. Chem. Commun., 1994, 1877-1878.
30. Shimizu, T.; Usui, T.; Machida, K.; Furuya, K.; Osada, H.; Nakata, T. Chemical modification of reveromycin A and its biological activities. Bioorg. Med. Chem. Lett., 2002, 12, 3363-3366.
31. Shimizu, T.; Usui, T.; Fujikura, M.; Kawatani, M.; Satoh, T.; Machida, K.; Kanoh, N.; Woo, J. T.; Osada, H.; Sodeoka, M. Synthesis and biological activities of reveromycin A and spirofungin A derivatives. Bioorg. Med. Chem. Lett., 2008, 18, 3756-3760.
32. Sutherland, R.; Boon, R. J.; Griffin, K. E.; Masters, P. J.; Slocombe, B.; White, A. R. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob. Agents Chemother., 1985, 27, 495-498.
33. Badder, A.; Garre, C. Uber antagonistenunterden bakterien, Corresp.-Bl. Sweiz.Aertze, 1887, 17, 385-392.
34. Fuller, A. T.; Mellows, G.; Woolford, M.; Banks, G. T.; Barrow, K. D.; Chain, E. B. Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens. Nature, 1971, 234, 416-417.
35. Alexander, R. G.; Clayton, J. P.; Luk, K.; Rogers, N. H.; King, T. J. The chemistry of pseudomonic acid. Part 1. The absolute configuration of pseudomonic acid A. J. Chem. Soc., Perkin Trans. I, 1978, 561-567.
36. Hughes, J.; Mellows, G. On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J. Antibiot., 1978, 31, 330-335.
37. Hughes, J.; Mellows, G.; Soughton, S. How does pseudomonas fluorescens, the producing organism of the antibiotic pseudomonic acid A, avoid suicide? FEBS Lett., 1980, 122, 322-334.
38. Pope, A. J.; Moore, K. J.; McVey, M.; Mensah, L.; Benson, N.; Osbourne, N.; Broom, M. J. B.; O'Hanlon, P. Characterization of isoleucyl-tRNA synthetase from Staphylococcus aureus. II. Mechanism of inhibition by reaction intermediate and pseudomonic acid analogues studied using transient and steady-state kinetics. J. Biol. Chem., 1998, 273, 31691-31701.
39. Brown, M. J. B.; Mensah, L. M.; Doyle, M. L.; Broom, N. J. P.; Osbourne, N.; Forrest, A. K.; Richardson, C. M.; O'Hanlon, P. J.; Pope, A. Rational design of femtomolar inhibitors of isoleucyl tRNA synthetase from a binding model for pseudomonic acid-A. J. Biochemistry, 2000, 39, 6003-6011.
40. Silvian, L. F.; Wang, J.; Steitz, T. A. Insights into editing from an ile-tRNA synthetase structure with tRNAile and mupirocin. Science, 1999, 285, 1074-1077.
41. Class, Y. J.; DeShong, P. The Pseudomonic Acids. Chem. Rev., 1995, 95, 1843-1857.
42. Clayton, J. P.; Oliver, R. S.; Rogers, N. P.; King, T. J. J. Chem. Soc. Perkin Trans. I, The chemistry of pseudomonic acid. Part 3. The rearrangement of pseudomonic acid A in acid and basic solution. 1979, 838-846.
43. Shiozawa, H.; Kagasaki, T.; Kinoshita, T.; Haruyama, H.; Domon, H.; Utsui, Y.; Kodama, K.; Takahashi, S. Thiomarinol, a new hybrid antimicrobial antibiotic produced by a marine bacterium. Fermentation, isolation, structure, and antimicrobial activity. J. Antibiot., 1993, 46, 1834-1842.
44. Shiozawa, H.; Takahashi, S. Configurational studies on thiomarinol. J. Antibiot., 1994, 47, 851-853.
45. Shiozawa, H.; Kagasaki, T.; Torikata, A.; Tanaka, N.; Fujimoto, K.; Hata, T.; Furukawa, Y.; Takahashi, S. Thiomarinols B and C, new antimicrobial antibiotics produced by a marine bacterium. J. Antibiot., 1995, 48, 907-909;
46. Shiozawa, H.; Shimada, A.; Takahashi, S. Thiomarinols D, E, F and G, new hybrid antimicrobial antibiotics produced by a marine bacterium; isolation, structure, and antimicrobial activity. J. Antibiot., 1997, 50, 449-452.
47. Stierle, D. B.; Stierle, A. A. Pseudomonic Acid-Derivatives from a Marine Bacterium. Experientia, 1992, 48, 1165-1169.
48. Yu, X. Y.; Finn, J.; Hill, J. M.; Wang, Z. G.; Keith, D.; Silverman, J.; Oliver, N A series of spirocyclic analogues as potent inhibitors of bacterial phenylalanyl-tRNA synthetases. Bioorg. Med. Chem. Lett., 2004, 14, 1339-1342.
49. Jarvest, R. L.; Erskine, S. G.; Forrest, A. K.; Fosberry, A. P.; Hibbs, M. J.; Jones, J. J.; O'Hanlon, P. J.; Sheppard, R. J.; Worby, A. Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase. Bioorg. Med. Chem. Lett., 2005, 15, 2305-2309.
50. Montgomery, J. I.; Toogood, P. L.; Hutchings, K. M.; Liu, J.; Narasimhan, L.; Braden, T.; Dermyer, M. R.; Kulynych, A. D.; Smith, Y. D.; Warmus, J. S.; Taylor, C. Discovery and SAR of benzyl phenyl ethers as inhibitors of bacterial phenylalanyl-tRNA synthetase. Bioorg. Med. Chem. Lett., 2009, 19, 665-669.
51. Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand efficiency: a useful metric for lead selection. Drug Discovery Today, 2004, 9, 430-431.
52. Leeson, P. D.; Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Disc., 2007, 6, 881-890.